Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Irinotecan in Recurrent Anaplastic Astrocytomas and Oligodendrogliomas
NCT00360828Phase 2Terminated
- Sponsor
- Moffitt Cancer Center
- Start
- Feb 2006
- Primary completion
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of irinotecan in anaplastic astrocytoma (AA), mixed glioma, Oligodendroglioma (OG), sponsored by Moffitt Cancer Center. Started Feb 2006; status: terminated.
02
Drugs
irinotecan
03
Conditions
anaplastic astrocytoma (AA)mixed gliomaOligodendroglioma (OG)
Beyond the preview
Go deeper on NCT00360828.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00360828.